Cannabidiol: State of the art and new challenges for therapeutic applications

…, G Faggiana, MC Proto, D Fiore, C Laezza… - Pharmacology & …, 2017 - Elsevier
Over the past years, several lines of evidence support a therapeutic potential of Cannabis
derivatives and in particular phytocannabinoids. Δ 9 -THC and cannabidiol (CBD) are the most …

Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma

…, I Matias, S Pisanti, L De Petrocellis, C Laezza… - … of Pharmacology and …, 2006 - ASPET
Δ 9 -Tetrahydrocannabinol (THC) exhibits antitumor effects on various cancer cell types, but
its use in chemotherapy is limited by its psychotropic activity. We investigated the antitumor …

Pharmacological actions of statins: a critical appraisal in the management of cancer

…, E Ciaglia, S Pisanti, A Santoro, C Laezza… - Pharmacological …, 2012 - ASPET
Statins, among the most commonly prescribed drugs worldwide, are cholesterol-lowering
agents used to manage and prevent cardiovascular and coronary heart diseases. Recently, a …

The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation

…, A Palmisano, T Bisogno, C Laezza… - Proceedings of the …, 1998 - National Acad Sciences
Anandamide was the first brain metabolite shown to act as a ligand of “central” CB1 cannabinoid
receptors. Here we report that the endogenous cannabinoid potently and selectively …

[HTML][HTML] Cannabinoids: therapeutic use in clinical practice

…, L Coppola, G Avilia, M Bifulco, C Laezza - International journal of …, 2022 - mdpi.com
Medical case reports suggest that cannabinoids extracted from Cannabis sativa have therapeutic
effects; however, the therapeutic employment is limited due to the psychotropic effect of …

Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell …

…, P Orlando, T Bisogno, C Laezza… - …, 2000 - academic.oup.com
Anandamide and 2-arachidonoylglycerol (2-AG), two endogenous ligands of the CB1 and
CB2 cannabinoid receptor subtypes, inhibit the proliferation of PRL-responsive human breast …

The endocannabinoid signaling system in cancer

S Pisanti, P Picardi, A D'Alessandro, C Laezza… - Trends in …, 2013 - cell.com
Changes in lipid metabolism are intimately related to cancer. Several classes of bioactive
lipids play roles in the regulation of signaling pathways involved in neoplastic transformation …

Inhibitory effects of cannabinoid CB1 receptor stimulation on tumor growth and metastatic spreading: actions on signals involved in angiogenesis and metastasis

G Portella, C Laezza, P Laccetti… - The FASEB …, 2003 - Wiley Online Library
Stimulation of cannabinoid CB 1 receptors by 2‐methyl‐arachidonyl‐2′‐fluoro‐ethylamide
(Met‐F‐AEA) inhibits the growth of a rat thyroid cancer cell‐derived tumor in athymic mice by …

Cannabinoids and cancer: pros and cons of an antitumour strategy

M Bifulco, C Laezza, S Pisanti… - British journal of …, 2006 - Wiley Online Library
In the last two decades, research has dramatically increased the knowledge of cannabinoids
biology and pharmacology. In mammals, compounds with properties similar to active …

Anandamide inhibits adhesion and migration of breast cancer cells

C Grimaldi, S Pisanti, C Laezza, AM Malfitano… - Experimental cell …, 2006 - Elsevier
The endocannabinoid system regulates cell proliferation in human breast cancer cells. We
reasoned that stimulation of cannabinoid CB 1 receptors could induce a non-invasive …